CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Altair Therapeutics

For profit

Also known as: ALTAIRE PHARMS INC | Altair Therapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

First marketed drug

Last known activity

May 3, 2018

Defunct as of Feb 1, 2011

Timeline

2000s

Jan 1, 2007
Altair Therapeutics— Founded

2010s

Feb 1, 2011
Altair Therapeutics— Defunct
Apr 29, 2013
ofloxacin— Marketing Organization
Dec 14, 2017
fluorescein— NDA Secondary Org

Drugs by trial phase (2 distinct, 2 trials)

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Asthma

Marketed drugs (7)

Recent trials (4)

NCT00941577Study directorPhase 2Oct 1, 2009
NCT00941577Lead sponsorPhase 2Oct 1, 2009
NCT00658749Lead sponsorPhase 1Apr 1, 2008
NCT00658749Study directorPhase 1Apr 1, 2008

Details

Founded: San Diego, CA, US Jan 1, 2007
Last known activity: May 3, 2018